Introducing...
The First New Zealand Chronic Obstructive Pulmonary Disease (COPD) Guidelines This live presentation has a limited attendance number, RVSP now to reserve your place!
Scan the QR code or go to Stayinformed.gskpro.co.nz to stay up to date on future respiratory events
Agenda 6:00 pm
Arrival and Nibbles
6:30 pm
Presentation Commences
7:30pm
Dinner and Discussion
9:00pm
Meeting Closes
Don't miss out!
Dr James Fingleton Dr Fingleton is a respiratory physician and Clinical Leader Respiratory at Wellington Regional Hospital, where he runs the severe asthma service. He is a Senior Clinical Lecturer at the University of Otago and Honorary Research Associate at Victoria University of Wellington. Dr Fingleton’s research interests focus on the treatment of airways disease, particularly severe asthma and COPD, with a particular interest in personalised medicine.
Date
03/03/2021
Timee
2021 will see the publication of New Zealand’s first COPD guidelines. These guidelines are designed as a quick reference to provide simple, practical, evidence-based recommendations for the diagnostic, assessment and management of Chronic Obstructive Pulmonary Disease (COPD) in clinical practice. Join Dr James Fingleton, a primary author of this guidelines as we walk our way through the key aspects of the guidelines.
Please RSVP by: To reserve your place at this meeting, choose one of the options below: Contact GSK Representative on:
Or Email:
Demelza Smith 021 916 051
Demelza.j.smith@gsk.com
6:00 pm If you have selected register by email, please send through the relevant details below
Venue(s)
Trinity Wharf 51 Dive Crescent Tauranga, 3110
Name Practice Name Profession Contact Email
For full product information or to report an adverse event, please contact GSK on 0800 808 500. GlaxoSmithKline New Zealand Ltd, Private Bag 106600, Downtown Auckland. GlaxoSmithKline New Zealand complies with the Privacy Act 2020. Details of our privacy policy can be found at https://nz.gsk.com/en-nz/privacy-policy/ If you require, you may access the information we hold about you by writing to the Privacy Officer, GlaxoSmithKline NZ, Level 11, 21 Queen St, Auckland 1010, New Zealand. ©2021 GSK group of companies or its licensor. Registered office: Level 11, 21 Queen Street, Auckland 1010, New Zealand. TAPS DA2124GS- PM-NZ-UCV-LBND-21JAN0001